90Y-Ibritumomab Tiuxetan: Revision history

7 October 2013

• curprev 03:3803:38, 7 October 2013‎ imported>Meg Taylor‎ 11,421 bytes +11,421‎ No edit summary

7 November 2010

• curprev 12:2412:24, 7 November 2010‎ imported>Kelsy Snyder‎ 11,636 bytes −13‎ →‎Expense
• curprev 12:2312:23, 7 November 2010‎ imported>Kelsy Snyder‎ 11,649 bytes −258‎ →‎Expense

6 November 2010

• curprev 17:0017:00, 6 November 2010‎ imported>Kelsy Snyder‎ 11,907 bytes +65‎ No edit summary
• curprev 16:5916:59, 6 November 2010‎ imported>Kelsy Snyder‎ 11,896 bytes 0‎ No edit summary
• curprev 16:5616:56, 6 November 2010‎ imported>Kelsy Snyder‎ 11,896 bytes +35‎ No edit summary
• curprev 16:5516:55, 6 November 2010‎ imported>Kelsy Snyder‎ 11,887 bytes +26‎ No edit summary
• curprev 16:5416:54, 6 November 2010‎ imported>Kelsy Snyder‎ 11,887 bytes +5‎ No edit summary
• curprev 16:5216:52, 6 November 2010‎ imported>Kelsy Snyder‎ 11,882 bytes +21‎ No edit summary
• curprev 16:5016:50, 6 November 2010‎ imported>Kelsy Snyder‎ 11,861 bytes +19‎ No edit summary
• curprev 16:4716:47, 6 November 2010‎ imported>Kelsy Snyder‎ 11,842 bytes +12‎ No edit summary
• curprev 16:4716:47, 6 November 2010‎ imported>Kelsy Snyder‎ 11,830 bytes +11,830‎ No edit summary
• curprev 16:4516:45, 6 November 2010‎ imported>Kelsy Snyder‎ 11,777 bytes +307‎ No edit summary
• curprev 16:4016:40, 6 November 2010‎ imported>Kelsy Snyder‎ 11,774 bytes +94‎ No edit summary
• curprev 16:3716:37, 6 November 2010‎ imported>Kelsy Snyder‎ 11,680 bytes +210‎ No edit summary
• curprev 16:3316:33, 6 November 2010‎ imported>Kelsy Snyder‎ 11,678 bytes +208‎ No edit summary
• curprev 16:2516:25, 6 November 2010‎ imported>Kelsy Snyder‎ 11,691 bytes +221‎ No edit summary
• curprev 16:1016:10, 6 November 2010‎ imported>Kelsy Snyder‎ 11,459 bytes −11‎ →‎References
• curprev 16:0616:06, 6 November 2010‎ imported>Kelsy Snyder‎ 11,470 bytes +6‎ →‎Clinical Efficacy
• curprev 16:0516:05, 6 November 2010‎ imported>Kelsy Snyder‎ 11,464 bytes −8‎ →‎Clinical Efficacy
• curprev 16:0416:04, 6 November 2010‎ imported>Kelsy Snyder‎ 11,472 bytes −11‎ →‎Clinical Efficacy
• curprev 15:5415:54, 6 November 2010‎ imported>Daniel Mietchen‎ m 11,483 bytes +11‎ please see Help:Index/Formatting/References on how to format references
• curprev 15:5315:53, 6 November 2010‎ imported>Kelsy Snyder‎ 11,472 bytes +11,472‎ →‎Expense
• curprev 15:5215:52, 6 November 2010‎ imported>Kelsy Snyder‎ 11,450 bytes +64‎ →‎Side Effects
• curprev 15:5015:50, 6 November 2010‎ imported>Kelsy Snyder‎ 11,386 bytes +480‎ →‎Warnings
• curprev 15:4815:48, 6 November 2010‎ imported>Kelsy Snyder‎ 11,308 bytes +48‎ →‎Medical Imaging
• curprev 15:4315:43, 6 November 2010‎ imported>Kelsy Snyder‎ 11,260 bytes +4‎ →‎Relapsed or Refractory B-cell NHL
• curprev 15:4215:42, 6 November 2010‎ imported>Kelsy Snyder‎ 11,256 bytes +67‎ →‎Medical Imaging
• curprev 15:3915:39, 6 November 2010‎ imported>Kelsy Snyder‎ 11,189 bytes +4‎ →‎Dosage and Administration
• curprev 15:3915:39, 6 November 2010‎ imported>Kelsy Snyder‎ 11,185 bytes +7‎ →‎Relapsed or Refractory B-cell NHL
• curprev 15:3815:38, 6 November 2010‎ imported>Kelsy Snyder‎ 11,178 bytes +113‎ →‎Relapsed or Refractory B-cell NHL
• curprev 15:3515:35, 6 November 2010‎ imported>Kelsy Snyder‎ 11,065 bytes +17‎ →‎Relapsed or Refractory B-cell NHL
• curprev 15:3415:34, 6 November 2010‎ imported>Kelsy Snyder‎ 11,048 bytes +142‎ →‎Dosage and Administration
• curprev 15:3215:32, 6 November 2010‎ imported>Kelsy Snyder‎ 10,922 bytes +8‎ →‎Mechanism of Action
• curprev 15:3115:31, 6 November 2010‎ imported>Kelsy Snyder‎ 10,914 bytes +8‎ No edit summary
• curprev 15:3015:30, 6 November 2010‎ imported>Kelsy Snyder‎ 10,910 bytes +4‎ No edit summary
• curprev 15:2615:26, 6 November 2010‎ imported>Kelsy Snyder‎ 10,906 bytes +93‎ →‎Mechanism of Action
• curprev 15:2415:24, 6 November 2010‎ imported>Kelsy Snyder‎ 10,845 bytes +4‎ No edit summary
• curprev 15:2315:23, 6 November 2010‎ imported>Kelsy Snyder‎ 10,841 bytes +32‎ No edit summary

3 November 2010

• curprev 10:2310:23, 3 November 2010‎ imported>Kelsy Snyder‎ 10,819 bytes +11‎ →‎Mechanism of Action
• curprev 10:0110:01, 3 November 2010‎ imported>Kelsy Snyder‎ 10,808 bytes +59‎ No edit summary
• curprev 09:5909:59, 3 November 2010‎ imported>Kelsy Snyder‎ 10,809 bytes +60‎ →‎References
• curprev 09:5709:57, 3 November 2010‎ imported>Kelsy Snyder‎ 10,749 bytes −56‎ →‎Medical Imaging
• curprev 09:5109:51, 3 November 2010‎ imported>Kelsy Snyder‎ 10,802 bytes −3‎ →‎Expense
• curprev 09:5009:50, 3 November 2010‎ imported>Kelsy Snyder‎ 10,805 bytes −4‎ →‎Warnings
• curprev 09:5009:50, 3 November 2010‎ imported>Kelsy Snyder‎ 10,809 bytes −2‎ →‎Warnings
• curprev 09:4809:48, 3 November 2010‎ imported>Kelsy Snyder‎ 10,811 bytes −1‎ →‎Expense
• curprev 09:4809:48, 3 November 2010‎ imported>Kelsy Snyder‎ 11,307 bytes +496‎ →‎Side Effects

1 November 2010

• curprev 05:0205:02, 1 November 2010‎ imported>David Finn‎ m 10,811 bytes −1‎ →‎Side Effects
• curprev 01:0601:06, 1 November 2010‎ imported>Howard C. Berkowitz‎ m 10,812 bytes −1‎ No edit summary
• curprev 01:0601:06, 1 November 2010‎ imported>Howard C. Berkowitz‎ 10,813 bytes +10,813‎ Wikipedia cannot be used as a source
• curprev 00:5900:59, 1 November 2010‎ imported>Howard C. Berkowitz‎ 11,034 bytes +11,034‎ No edit summary

31 October 2010

• curprev 13:3013:30, 31 October 2010‎ imported>Kelsy Snyder‎ 11,269 bytes +11,269‎ New page: {{subpages}} <!-- Please ignore (but don't delete) any formatting that you are not familiar with. Others will probably chime in to help you set things up. --> == '''90Y-Ibritumomab Tiux...